Computational insights into the aggregation mechanism and amyloidogenic core of aortic amyloid medin polypeptide

Fengjuan Huang1, Jiajia Yan2, Xiaohan Zhang2

  • 1Ningbo Institute of Innovation for Combined Medicine and Engineering (NIIME), Ningbo Medical Center Lihuili Hospital, Ningbo 315211, China.

Insights

Medin amyloid aggregation, a cause of arterial stiffening, was studied using molecular dynamics. Segments 21-30 and 41-50 showed significant self-assembly, identifying key residues for potential drug targets against aortic medial amyloidosis.

Area of Science:

  • Biophysics
  • Molecular Biology
  • Cardiovascular Research

Background:

  • Medin amyloid is found in most individuals over 50, contributing to arterial stiffening and cerebrovascular issues.
  • The precise aggregation mechanism of medin amyloid remains poorly understood, hindering therapeutic development.

Purpose of the Study:

  • To investigate the self-assembly dynamics of individual medin peptide segments.
  • To identify specific regions and residues critical for medin amyloid formation.
  • To provide insights for developing inhibitors against aortic medial amyloidosis (AMA).

Main Methods:

  • Atomistic discrete molecular dynamics (DMD) simulations were used to study five 10-residue segments of the medin peptide.
  • Microsecond-timescale simulations analyzed the self-assembly dynamics and oligomer formation.
  • Residue pairwise contact frequency analysis identified key interacting residues.

Main Results:

  • Medin segments 1-10 and 11-20 did not form stable oligomers.
  • Medin segment 31-40 showed moderate, dynamic β-sheet oligomerization.
  • Medin segments 21-30 and 41-50 exhibited significant self-assembly into stable β-sheet-rich oligomers.
  • Residues 22-26 and 43-49 were identified as critical for the self-assembly of medin 21-30 and 41-50, respectively.

Conclusions:

  • Specific medin peptide segments (21-30 and 41-50) possess inherent self-assembly capabilities.
  • Key residues (22-26 and 43-49) are crucial for forming the β-sheet core of medin amyloid.
  • These findings offer a theoretical basis for designing targeted amyloid inhibitors for AMA treatment.